OBJECTIVE: Sepsis impairs the activation of the interleukin (IL)-6 dependent transcription factor signal transducer and activator of transcription (STAT)-3. However, the molecular basis for depressed functionality has not been characterized. In this study, we test the hypothesis that altered signal transduction results from a change in the activation state of one or more of the components of the intracellular IL-6-linked pathway. DESIGN: Randomized prospective experimental study. SETTING: University medical laboratory. SUBJECTS: Male, 6-8-week-old C57/Bl6 mice. INTERVENTIONS: Cecal ligation and single puncture (CLP) or cecal ligation and double puncture (2CLP) was used to model mild and fulminant sepsis, respectively. Sham-operated and unoperated animals served as controls. All animals were fluid resuscitated at the time of surgery and every 24 hours thereafter. Surviving animals were euthanized at 3, 6, 16, 24, 48, and 72 hours; blood samples were obtained and liver tissue was harvested. MEASUREMENTS AND MAIN RESULTS: Serum IL-6 levels were elevated in both CLP and 2CLP relative to controls. STAT-3 DNA binding activity and nuclear phosphorylated-STAT-3 levels were elevated in CLP but decreased abruptly 24 hours after 2CLP. This 2CLP-induced alteration was associated with attenuated phosphorylation of the key transcellular glycoprotein (gp) 130. Abundance and phosphorylation of the other key component of IL-6 signal transduction pathway, janus kinase-1, was unchanged following either CLP or 2CLP. 2CLP also did not cause disassociation of the gp130-janus kinase-1 complex. CONCLUSIONS: Impaired gp130 phosphorylation may be responsible for IL-6 hyporesponsiveness during sepsis.
OBJECTIVE:Sepsis impairs the activation of the interleukin (IL)-6 dependent transcription factor signal transducer and activator of transcription (STAT)-3. However, the molecular basis for depressed functionality has not been characterized. In this study, we test the hypothesis that altered signal transduction results from a change in the activation state of one or more of the components of the intracellular IL-6-linked pathway. DESIGN: Randomized prospective experimental study. SETTING: University medical laboratory. SUBJECTS: Male, 6-8-week-old C57/Bl6 mice. INTERVENTIONS: Cecal ligation and single puncture (CLP) or cecal ligation and double puncture (2CLP) was used to model mild and fulminant sepsis, respectively. Sham-operated and unoperated animals served as controls. All animals were fluid resuscitated at the time of surgery and every 24 hours thereafter. Surviving animals were euthanized at 3, 6, 16, 24, 48, and 72 hours; blood samples were obtained and liver tissue was harvested. MEASUREMENTS AND MAIN RESULTS: Serum IL-6 levels were elevated in both CLP and 2CLP relative to controls. STAT-3 DNA binding activity and nuclear phosphorylated-STAT-3 levels were elevated in CLP but decreased abruptly 24 hours after 2CLP. This 2CLP-induced alteration was associated with attenuated phosphorylation of the key transcellular glycoprotein (gp) 130. Abundance and phosphorylation of the other key component of IL-6 signal transduction pathway, janus kinase-1, was unchanged following either CLP or 2CLP. 2CLP also did not cause disassociation of the gp130-janus kinase-1 complex. CONCLUSIONS: Impaired gp130 phosphorylation may be responsible for IL-6hyporesponsiveness during sepsis.
Authors: R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl Journal: J Immunol Date: 2001-06-01 Impact factor: 5.422
Authors: R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove Journal: Immunity Date: 1999-01 Impact factor: 31.745
Authors: Charlotte A Haaxma; Patrick K Kim; Kenneth M Andrejko; Nichelle R Raj; Clifford S Deutschman Journal: Shock Date: 2003-01 Impact factor: 3.454
Authors: Laurie E Kilpatrick; Stephen W Standage; Haiying Li; Nichelle R Raj; Helen M Korchak; Marla R Wolfson; Clifford S Deutschman Journal: J Leukoc Biol Date: 2010-08-19 Impact factor: 4.962
Authors: Antti Turunen; Antti Kuuliala; Harri Mustonen; Pauli Puolakkainen; Leena Kylänpää; Krista Kuuliala Journal: Pancreas Date: 2021 May-Jun 01 Impact factor: 3.327
Authors: Matthew D Taylor; Mariana R Brewer; Ana Nedeljkovic-Kurepa; Yihe Yang; Kalpana S Reddy; Mabel N Abraham; Betsy J Barnes; Clifford S Deutschman Journal: Front Immunol Date: 2020-08-12 Impact factor: 7.561
Authors: Matthew D Taylor; Tiago D Fernandes; Alexander P Kelly; Mabel N Abraham; Clifford S Deutschman Journal: Front Immunol Date: 2020-11-20 Impact factor: 7.561
Authors: Daniel E Leisman; Tiago D Fernandes; Vanesa Bijol; Mabel N Abraham; Jake R Lehman; Matthew D Taylor; Christine Capone; Omar Yaipan; Rinaldo Bellomo; Clifford S Deutschman Journal: Kidney Int Date: 2020-08-31 Impact factor: 10.612
Authors: Clifford S Deutschman; Judith Hellman; Ricard Ferrer Roca; Daniel De Backer; Craig M Coopersmith Journal: Crit Care Med Date: 2020-08 Impact factor: 9.296